DEGRADABLE HAEMOSTAT COMPOSITION

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20170258958A1
SERIAL NO

15600875

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In one aspect, the present invention includes a haemostat composition that includes a chitosan, chitosan salt or chitosan derivative, and a physiologically acceptable acid, which is present in the amount of 45-70% by weight of the haemostat composition. The haemostat composition is able to safely gradually and fully degrade in a human or animal body within about 30 days and so can be utilised by physicians to stem a flow of blood and promote healing both after as well as during surgical procedures.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDTRADE PRODUCTS LIMITEDCREWE CHESHIRE CW1 6GL

International Classification(s)

loading....
  • 2017 Application Filing Year
  • C08B Class
  • 363 Applications Filed
  • 229 Patents Issued To-Date
  • 63.09 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances2017201820192020202120222023202420250255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gladman, June Cheshire, GB 10 1
Hardy, Craig Cardigan, GB 32 133
Hoggarth, Andrew Cheshire, GB 29 79

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 0 Citation Count
  • C08B Class
  • 0 % this patent is cited more than
  • 8 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges103983101 - 1011 - 2021 - 3005101520253035404550556065707580859095100105110

Forward Cite Landscape

Load Citation